Localized Delivery System for Cancer Drug, Phenstatin, Using N-Isopropylacrlyamide

Brent Vernon (Inventor)

Research output: Patent

Abstract

This invention seeks to improve the delivery of the cancer chemotherapy agent, phenstatin, in the treatment of various bulk cancers using a "smart polymer". Specifically, it involves the design of an injectable drug delivery system to locally deliver phenstatin using temperature based polymers based on N-isopropylacrylamide. The polymer-drug conjugate would be water soluble allowing the system to be injected as a liquid, and subsequently would gel in vivo at the site of delivery.
Original languageEnglish (US)
StatePublished - Jun 20 2002

Fingerprint

Drug Delivery Systems
Polymers
Neoplasms
Antineoplastic Agents
Gels
Injections
Temperature
Water
Pharmaceutical Preparations
Therapeutics

Cite this

@misc{66eb75f8498f4f0288fa933a20db5352,
title = "Localized Delivery System for Cancer Drug, Phenstatin, Using N-Isopropylacrlyamide",
abstract = "This invention seeks to improve the delivery of the cancer chemotherapy agent, phenstatin, in the treatment of various bulk cancers using a {"}smart polymer{"}. Specifically, it involves the design of an injectable drug delivery system to locally deliver phenstatin using temperature based polymers based on N-isopropylacrylamide. The polymer-drug conjugate would be water soluble allowing the system to be injected as a liquid, and subsequently would gel in vivo at the site of delivery.",
author = "Brent Vernon",
year = "2002",
month = "6",
day = "20",
language = "English (US)",
type = "Patent",

}

TY - PAT

T1 - Localized Delivery System for Cancer Drug, Phenstatin, Using N-Isopropylacrlyamide

AU - Vernon, Brent

PY - 2002/6/20

Y1 - 2002/6/20

N2 - This invention seeks to improve the delivery of the cancer chemotherapy agent, phenstatin, in the treatment of various bulk cancers using a "smart polymer". Specifically, it involves the design of an injectable drug delivery system to locally deliver phenstatin using temperature based polymers based on N-isopropylacrylamide. The polymer-drug conjugate would be water soluble allowing the system to be injected as a liquid, and subsequently would gel in vivo at the site of delivery.

AB - This invention seeks to improve the delivery of the cancer chemotherapy agent, phenstatin, in the treatment of various bulk cancers using a "smart polymer". Specifically, it involves the design of an injectable drug delivery system to locally deliver phenstatin using temperature based polymers based on N-isopropylacrylamide. The polymer-drug conjugate would be water soluble allowing the system to be injected as a liquid, and subsequently would gel in vivo at the site of delivery.

M3 - Patent

ER -